Bank Of America Corp Spectrum Pharmaceuticals Inc Transaction History

Bank Of America Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.65 - $1.31 $127,860 - $257,688	-196,709 Reduced 66.79%	97,803 $93,000
Q1 2023 May 12, 2023	BUY	$0.38 - $1.07 $53,215 - $149,844	140,042 Added 90.66%	294,512 $220,000
Q4 2022 Feb 10, 2023	SELL	$0.32 - $0.52 $206,510 - $335,578	-645,344 Reduced 80.69%	154,470 $57,000
Q3 2022 Nov 14, 2022	BUY	$0.43 - $1.56 $307,991 - $1.12 Million	716,259 Added 857.23%	799,814 $344,000
Q2 2022 Aug 12, 2022	BUY	$0.7 - $1.4 $8,090 - $16,181	11,558 Added 16.05%	83,555 $65,000
Q1 2022 May 16, 2022	SELL	$0.63 - $1.59 $4.3 Million - $10.8 Million	-6,822,659 Reduced 98.96%	71,997 $92,000
Q4 2021 Feb 08, 2022	BUY	$1.27 - $2.42 $8.59 Million - $16.4 Million	6,763,746 Added 5166.71%	6,894,656 $8.76 Million
Q3 2021 Nov 15, 2021	SELL	$2.15 - $3.82 $553,545 - $983,508	-257,463 Reduced 66.29%	130,910 $285,000
Q2 2021 Sep 13, 2021	BUY	$2.89 - $4.45 $1.12 Million - $1.73 Million	388,373 New	388,373 $1.46 Million

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.